Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals

Covid-19 Clinical Trial

Official title:

Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at the University Hospitals of Strasbourg : A Retrospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04706260
• Other study ID #: 7839
• Status: Completed
• Start date: April 14, 2020
• Est. completion date: April 14, 2021

Study information

• Verified date: January 2021
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A SARS-CoV-2 infection emerged in China in December 2019, the severity of which is linked to acute respiratory distress syndrome1. The rate of emergency visits in Bas-Rhin for suspected Covid-19 increased, compared to the French average, at the end of the 10th week of 2020.

Compared to the onset of symptoms, Chinese studies estimate the onset of dyspnea on the 7th day3 and admission to the emergency room between the 5th and the 9th day4. But this duration varies according to the epidemic period5, the geographical location6 and a later emergency admission is associated with an increase in mortality in the Chinese population7.

The need for oxygen, which is not noted in Chinese studies8, is a reflection of the onset of respiratory worsening and a major factor in hospitalization. There is no study on the changing profile of the French population to date its onset.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 600
• Est. completion date: April 14, 2021
• Est. primary completion date: April 14, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male or female aged 18 or over

• Admitted to the NHC emergency room and hospitalized at the Strasbourg University Hospitals (HUS) between 06/03/2020 and 05/04/2020.

• With SARS-CoV-2 RT-PCR on a positive nasopharyngeal sample taken at the SU.

Exclusion Criteria:

• Refusal to participate in the study

• Return home from the SU

• Transfer to another establishment

• Patient under the protection of justice

• Patient under guardianship, curatorship

Related Conditions & MeSH terms

• Covid-19

Locations

Country	Name	City	State
France	Adult Emergency Department - Strasbourg University Hospitals	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective evaluation of the clinical evolution and becoming of adult patients infected with Covid-19 hospitalized at the University Hospitals of Strasbourg from the Emergency Structure		Files analysed retrospectily from March 06, 2020 to April 05, 2020 will be examined]